GSK gets FDA accelerated approval for Jemperli to treat endometrial cancer
The FDA accelerated approval is based on the results from the dMMR endometrial cancer cohort of the ongoing…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
23 Apr 21
The FDA accelerated approval is based on the results from the dMMR endometrial cancer cohort of the ongoing…
22 Apr 21
J.POD 2 EU marks Evotec’s second cGMP biomanufacturing facility and will be the first commercial biomanufacturing facility in…
21 Apr 21
The PRAC recommendation enables J&J to resume the supply of its Covid-19 vaccine in the European Union (EU),…
21 Apr 21
Avigan is an anti-influenza drug, approved for domestic use in March 2014, for the treatment of new or…
20 Apr 21
Adagio will use the funding to advance its lead candidate ADG20, a single agent intended for both treatment…
Active Pharmaceutical Ingredients and IntermediatesPharmaceuticals
20 Apr 21
The EC approval is based on the Phase 3 IKEMA study, which showed that Sarclisa plus standard of…
19 Apr 21
AstraZeneca has initially announced the acquisition of the US-based pharmaceutical firm for a total consideration of $39bn in…
19 Apr 21
The FDA approval is based on CheckMate-649, a Phase 3 trial evaluating Opdivo in combination with chemotherapy
16 Apr 21
The business combination would add highly complementary services that further enhance Thermo Fisher’s value proposition for pharma and…
16 Apr 21
Novartis will dedicate its large-scale biologics facility in Singapore for the production of API of Roche’s Actemra/RoActemra